9 results
·
18ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
IMMUNOWELL MYCOPLASMA PNEUMONIA ANTIBODY (IGM) TEST (3130)
FDA 510(k)
FDA Class 1
·Microbiology
P.F.C. SIGMA
FDA UDI
DEPUY ORTHOPAEDICS, INC.·10603295245537·P.F.C. SIGMA RP CURVED TIBIAL INSERT TRIAL SZ 5...
AST S.C.E. (GOT)
FDA 510(k)
FDA Class 2
·Clinical Chemistry
DyeVert Plus Contrast Modulation/Monitoring System, Contrast Monitoring System
FDA 510(k)
FDA Class 2
·Cardiovascular
HEARTSTART FR3 ECG, BASIC BUNDLE, UKENG
FDA Adverse Event
Malfunction
·PHILIPS MEDICAL SYSTEMS·Product code MKJ·June 11, 2014
DISPOSABLE DISTAL ATTACHMENT
FDA Adverse Event
Malfunction
·OLYMPUS MEDICAL SYSTEMS CORPORATION·Product code LFL·January 25, 2013
FILTERWIRE EZ EMOBLIC PROTECTION SYSTEM
FDA Adverse Event
Injury
·BOSTON SCIENTIFIC - SAN JOSE·Product code NFA·January 18, 2011
BIOMET 3i, PROVIDE IMPRESSION COPING KITS, Catalog # PRK484, PRK485, PRK654, and PRK655 BIOMET 3i Restorative Products are intended for use as an accessory to endosseous dental implants for placement in the maxilla and mandible. Provisional Abutments are intended for use as an accessory to endosseous dental implants to support a prosthetic device in a partially or fully edentulous patient. They are intended for use to support a prosthesis in the mandible or maxilla for up to 180 days during endosseous and gingival healing, and are for non-occlusal loading of provisional restorations.
FDA Enforcement
Class II
·Terminated·Biomet 3i, LLC·January 13, 2016
Stryker T2 Arthrodesis Nailing System. Manufacturer: Stryker Trauma GmbH, Professor-Kuntscher-Str. 1-5, 24232 Schonkirchen Germany. Distributed in the USA by Stryker Orthopaedics, 325 Corporate Drive, Mahwah, NJ 07430. The T2 Arthrodesis Nail is intended for the treatment of Knee Arthrodesis. The design of the T2 Arthrodesis Nail features a unique curvature which incorporates both femur ante curvature and knee valgus bend. Indications: Aseptic failed total knee arthro-plasty with or without bone loss; Failed external fixation, non unions and malunions; Periarticular fractures where repair is not possible; Pathologic fractures and tumor resections; Pseudoarthrosis and correct osteotomy; Ipsilateral femur fractures; and Open and closed femoral fractures.
FDA Enforcement
Class II
·Terminated·Stryker Howmedica Osteonics Corp.·July 25, 2012